Success Metrics

Active Trials
1(25%)

Phase Distribution

Ph not_applicable
1
25%
Ph phase_3
2
50%
Ph phase_4
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(4)

Detailed Status

Not yet recruiting3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 32 (50.0%)
Phase 41 (25.0%)
N/A1 (25.0%)

Trials by Status

recruiting125%
not_yet_recruiting375%

Recent Activity

1 active trials
Showing 4 of 4
not_yet_recruitingphase_3

Colchicine in Chronic Limb-Threatening Ischemia

NCT07536373
not_yet_recruitingphase_3

PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis

NCT07232069
recruitingnot_applicable

Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory Therapy Efficacy in ACS Patients

NCT07064109
not_yet_recruitingphase_4

Colchicine in Patients with Heart Failure with Preserved Ejection Fraction and Inflammation

NCT06604611

Clinical Trials (4)

Showing 4 of 4 trials
NCT07536373Phase 3

Colchicine in Chronic Limb-Threatening Ischemia

Not Yet Recruiting
NCT07232069Phase 3

PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis

Not Yet Recruiting
NCT07064109Not Applicable

Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory Therapy Efficacy in ACS Patients

Recruiting
NCT06604611Phase 4

Colchicine in Patients with Heart Failure with Preserved Ejection Fraction and Inflammation

Not Yet Recruiting

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4